Global Melanoma Scanner Market is set to reach USD 850 million by 2025


Posted June 4, 2018 by Steveblade

According to Goldstein Research, global melanoma scanner market is expected to reach USD 850 million by 2025, expanding at a CAGR of 7.6% over the forecast period, 2017-2025.

 
According to Goldstein Research, global melanoma scanner market is expected to reach USD 850 million by 2025, expanding at a CAGR of 7.6% over the forecast period, 2017-2025. The growing skin cancer therapeutics market with increasing prevalence of melanoma skin cancer cases is majorly driving the market growth. Global melanoma scanner market segmentation has been done on the basis of product type, skin melanoma, end-user and geography. Handheld melanoma scanner dominated the global melanoma scanner market with 65% market share in 2017, attributed to hand-held device are easy to learn and use, and it rapidly provides accurate images of the melanin, blood, and collagen below the mole or lesion. Global Melanoma scanner market is dominated by North America region owing to increasing cases of melanoma In Canada, melanoma is the seventh most common cancer, with about 6,000 new cases estimated in 2013 (3,300 men and 2,700 women) and an age-standardized incidence rate of 13.4 per 100,000 people (15.1 for men and 12.2 for women).
Browse Full Report: https://www.goldsteinresearch.com/report/global-melanoma-scanner-market-size
Market Segmentation
On the basis of our in-depth analysis, Global Melanoma Scanner Market can be segmented as follows:
By Product Type
• Standalone Melanoma Scanner
• Handheld Melanoma Scanner
By Skin Melanoma
• Superficial Spreading Melanoma
• Nodular Melanoma
• Lentigo Maligna
• Acral Lentiginous Melanoma
By End User
• Hospitals
• Clinics
• Cancer Research Organizations
By region
• North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
• Global (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Global) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Asia Pacific (China, Japan, India, Singapore, South Korea, Global, New Zealand and Rest of Global) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
• Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
“Global Melanoma Scanner Market Outlook 2024” contains detailed overview of the Global Melanoma scanner market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by prduct type, by skin melanoma and end-users.
Further, for the in-depth analysis, Melanoma Scanner Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This industry analysis report also includes competitive outlook of some of the major players profiling of companies such as Strata Skin Sciences, Verisante, MedX Health, Abbott Laboratory, Medtronic, Siemens AG, Baxter International Inc., Agilent Technology, Roche, AstraZeneca, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the Global Melanoma scanner market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-melanoma-scanner-market-size
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Global, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare industry research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.
Contact us for more details
Steve Blade
(Global Sales Head)
USA: + 1-646-568-7747
Canada: 1-437-886-1181
UK: +44-203-318-6627
[email protected]
www.goldsteinresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Steve Blade
Website Global Melanoma Scanner Market
Phone +1-646-568-7747
Business Address 99 Wall Street ,Suite No- 527, New York, NY 10005
Country United States
Categories Reports
Tags elanoma scanner market size , melanoma scanner market , melanoma scanner market report , melanoma scanner market trends
Last Updated June 4, 2018